To unveil the underlying mechanisms of the anti-cancer effect of fisetin, a cell survival signalling pathway, PI3K/AKT/mTOR, was examined by measuring gene expression of PI3K, AKT, mTOR and NF-κB. The gene discussed is NFKB1; the disease is cancer.